New perspectives in antiplatelet therapyA Tello-Montoliu
Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, Ctra Madrid Cartagena Murcia, 30120, Spain
Curr Med Chem 19:406-27. 2012
..This review summarizes the mechanisms of action and current clinical evaluation of these novel antiplatelet agents...
Statins and postoperative risk of atrial fibrillation following coronary artery bypass graftingFrancisco Marin
Department of Cardiology, Hospital General University of Alicante, Alicante, Spain
Am J Cardiol 97:55-60. 2006
..Statin use may be protective against AF after coronary artery bypass grafting, possibly due to alterations in the extracellular matrix and remodeling after coronary artery bypass grafting...
Pharmacogenetics in cardiovascular antithrombotic therapyFrancisco Marin
Cardiology Department, Hospital General Universitario, c Pintor Baeza s n, Alicante, Spain
Curr Med Chem Cardiovasc Hematol Agents 3:357-64. 2005
..The present review article explores the genetic influence on antithrombotic drug efficacy, analysing the modulating role of different polymorphisms on individuals' response to drugs commonly used in current day practice...
[The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers]Francisco Marin
Servicio de Cardiologia, Hospital General de Alicante, Pintor Baeza s n, 03002 Alicante, Spain
Rev Esp Cardiol 59:537-44. 2006
..Our aims were to describe the characteristics of HCM patients who received ICDs at three hospitals in Spain, and to study indications for device implantation and the results of follow-up in device users...
Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillationF Marin
Department of Cardiology, General Hospital of Alicante, Pintor Baeza s n, Alicante 03002, Spain
Heart 90:1162-6. 2004
....
The pharmacogenetics of antiplatelet drugsFrancisco Marin
Servicio de Cardiologia, Hospital Universitario Virgen de la Arrixaca, Madrid Cartagen s n El Palmar, Murcia, 30008 Spain
Curr Opin Investig Drugs 8:213-8. 2007
..This review explores the genetic influences on antiplatelet drug efficacy by analyzing the modulating role of different genetic polymorphisms on individual responses to antiplatelet therapy...
Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillationVanessa Roldan
Hematology Unit, Hospital San Vicente, Alicante, Spain
Am J Cardiol 95:881-2. 2005
..Interleukin-6 levels, but not prothrombin fragment 1 + 2, correlates with a point-based score for stroke risk in atrial fibrillation, even after oral anticogulation...
Role of factor XIII Val34Leu polymorphism in patients <45 years of age with acute myocardial infarctionVanessa Roldan
Hematology Unit, Hospital de San Vicente, Alicante, Spain
Am J Cardiol 91:1242-5. 2003
Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?Juan M Ruiz-Nodar
Department of Cardiology, Hospital General Universitario de Alicante, Alicante, Spain
Circ Cardiovasc Interv 5:459-66. 2012
..Despite the guidelines, this approach has never been tested in a cohort of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation...
An evaluation of the CHADS₂ stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularizationJuan M Ruiz-Nodar
Department of Cardiology, Hospital General Universitario de Alicante, Alicante, Spain
Chest 139:1402-9. 2011
..We evaluated whether the CHADS(2) score was adequate for TE risk stratification while assessing cardiac risk in patients with AF revascularized with coronary artery stents...
Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathyFrancisco Cambronero
Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, and Centro Regional de Hemodonación, Universidad de Murcia, Murcia, Spain
Thromb Res 126:e46-50. 2010
..We hypothesised that vWf could be raised in patients with HCM and be related to different variables associated with severity of HCM...
Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulationEva Jover
Servicio de Cardiologia, Hospital Universitario Virgen de la Arrixaca, Universidad de Murcia, Ctra Madrid Cartagena s n, El Palmar, Murcia, Spain
Rev Esp Cardiol (Engl) 65:627-33. 2012
....
Synergistic association between hypercholesterolemia and the C46T factor XII polymorphism for developing premature myocardial infarctionVanessa Roldan
Centro Regional de Hemodonacion, University of Murcia, Murcia, Spain
Thromb Haemost 94:1294-9. 2005
..This effect could be associated with an increased pro-inflammatory state, as the 46T allele associates with high levels of CRP...
Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillationPilar Gallego
Hematology and Medical Oncology Unit, Hospital Universitario Morales Meseguer, University of Murcia, Murcia, Spain
Circ Arrhythm Electrophysiol 5:312-8. 2012
..We tested the usefulness of the HAS-BLED score for predicting both major bleeding and cardiovascular events in a cohort of anticoagulated patients with AF...
Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathySilvia Montoro-García
Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, University of Murcia, Spain
Eur J Intern Med 23:169-74. 2012
..We hypothesized that GDF-15 could be related to disease severity and functional status in patients with hypertrophic cardiomyopathy (HCM)...
Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patientsVanessa Roldan
Hematology and Medical Oncology Unit, Hospital Universitario Morales Meseguer, University of Murcia, Murcia, Spain
J Am Coll Cardiol 57:2496-504. 2011
..The purpose of this study was to evaluate the prognostic value of plasma von Willebrand factor (vWF) levels and fibrin d-dimer in a large cohort of anticoagulated permanent atrial fibrillation (AF) patients...
CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosisDiana Hernandez-Romero
Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
Ann Med 42:439-46. 2010
..We recently described that CALU polymorphism A29809G was related to acenocoumarol requirements, and we wanted to evaluate its role in arterial calcification and prognosis...
Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke riskVanessa Roldan
Centro de Hemodonación, Universidad de Murcia, Murcia, Spain
Ann Med 40:553-9. 2008
..Other functional polymorphisms were also tested...
A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarctionFrancisco Marin
Cardiology Department, Hospital General Universitario, Alicante, Spain
J Am Coll Cardiol 45:25-9. 2005
..The aim of this study was to evaluate the pharmacogenetic role of the factor XIII (FXIII) valine 34 leucine (Val34Leu) polymorphism in the fibrinolytic therapy of acute myocardial infarction (MI)...
Are there ethnic differences in the circadian variation in onset of acute myocardial infarction? A comparison of 3 ethnic groups in Birmingham, UK and Alicante, SpainFrancisca López
Coronary Care Unit, Hospital General Universitario, Alicante, Spain
Int J Cardiol 100:151-4. 2005
..Further studies are required to determine the pathophysiological mechanism(s) underlying these differences...
Influence of CYP2C19 polymorphisms in platelet reactivity and prognosis in an unselected population of non ST elevation acute coronary syndromeAntonio Tello-Montoliu
Servicio de Cardiologia, Hospital Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain
Rev Esp Cardiol (Engl) 65:219-26. 2012
....
Gadolinium-enhanced cardiovascular magnetic resonance and exercise capacity in hypertrophic cardiomyopathyAntonio Romero-Puche
Servicio de Cardiologia, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
Rev Esp Cardiol 61:853-60. 2008
..Our objective was to study the relationship between the degree of myocardial fibrosis observed by cardiac magnetic resonance and exercise capacity...
The prognostic value of biomarkers after a premature myocardial infarctionJavier Pineda
Department of Cardiology, Hospital General Universitario Alicante, Alicante, Spain
Int J Cardiol 143:249-54. 2010
..We hypothesised that abnormalities of these biological systems would contribute to outcome of coronary artery disease presenting at a young age...
Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathyVanessa Roldan
Centro Regional de Hemodonacion, University of Murcia, Murcia, Spain
Am Heart J 156:85-91. 2008
....
Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathyVictoria Moreno
Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
J Card Fail 16:950-6. 2010
..Therefore we hypothesized that increased hs-TnT levels are related to different variables associated with myocardial remodeling, such as the presence of fibrosis assessed with cardiac magnetic resonance imaging (MRI)...
Preoperative statin therapy and troponin T predict early complications of coronary artery surgeryDomingo A Pascual
Department of Cardiology, Hospital Universitario Arrixaca, Murcia, Spain
Ann Thorac Surg 81:78-83. 2006
..We sought to examine the association between preoperative statin therapy, systemic inflammation, and myocardial ischemia with the occurrence of early cardiac complications after coronary artery bypass grafting surgery...
Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stentingLuis Caballero
Cardiology Unit, Hospital Universitario Virgen de la Arrixaca, University of Murcia, Ctra Madrid Cartagena s n Ctra Madrid Cartagena s n, Murcia 30120, Spain
Age Ageing 42:70-5. 2013
..Dual antiplatelet therapy is recommended in these patients, requiring a period of triple therapy with dual antiplatelet agent plus oral anticoagulation (OAC). Concerns remain regarding the appropriateness of OAC in octogenarians...
Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?Antonio Tello-Montoliu
Cardiology Department, Hospital General Universitario, Alicante, Spain
J Thromb Thrombolysis 21:163-6. 2006
..The aim of the present study was to assess the fibrinolytic system after strenuous exercise in healthy people and explored the influence of smoking habit...
Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillationVanessa Roldan
Hematology Unit, Hospital San Vicente, Alicante, Spain
Thromb Res 116:321-5. 2005
..Further prospective studies are needed to assess the prognostic role of prothrombotic indices in AF in relation to stroke and thromboembolic events, and their role in complementing clinical risk stratification schemas...
High-sensitivity troponin T and copeptin in non-ST acute coronary syndromes: implications for prognosis and role of hsTnT and copeptin in non-STEACSDiana Hernandez-Romero
Servicio de Cardiologia, Hospital Universitario Virgen de la Arrixaca, 30120 Murcia, Spain
ScientificWorldJournal 2012:578616. 2012
..Abnormalities of serum hsTnT and copeptin levels in non-STEACS and negative TnT, could have prognostic implications...
Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosisJuan M Ruiz-Nodar
Department of Cardiology, Hospital General Universitario de Alicante, Alicante, Spain
J Am Coll Cardiol 51:818-25. 2008
..This study was designed to review outcomes in relation to antithrombotic therapy management strategies for patients with atrial fibrillation (AF) who undergo percutaneous coronary intervention (PCI) with stenting...
Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implicationsEduardo Payá
Department of Cardiology, Hospital General Universitario, Alicante, Spain
J Card Fail 14:414-9. 2008
..The aim of the present study was to describe the clinical characteristics and the presence of risk factors for sudden death in a series of patients from 2 referral centers for HCM in relation to late gadolinium enhancement in CMR...
Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarctionVanessa Roldan
Hematology Unit, Hospital de San Vicente, Alicante, Spain
Am Heart J 148:602-5. 2004
..We sought to evaluate the role of this polymorphism in premature myocardial infarction because genetic risk factors have more relevance in the development of disease in young patients...
The prognostic role of the adiponectin levels in atrial fibrillationDiana Hernandez-Romero
Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, Universidad de Murcia, Murcia 30008, Spain
Eur J Clin Invest 43:168-73. 2013
..The aim is to evaluate whether plasma adiponectin can be predictive of cardiovascular risk in anticoagulated patients with AF...
Mild kidney disease as a risk factor for major bleeding in patients with atrial fibrillation undergoing percutaneous coronary stentingSergio Manzano-Fernández
Sergio Manzano Fernández, MD, PhD, Cardiology Department, University Hospital Virgen de la Arrixaca, C Madrid Cartagena s n CP 30120, Murcia, Spain, Tel 34 968399445, Fax 34 968369662, E mail
Thromb Haemost 107:51-8. 2012
..Future studies should assess the potential role of incorporating mild KD into the bleeding risk scales to improve the stratification of these patients...
Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillationFrancisco Marin
Cardiology Service, Hospital General Universitario, c Pintor Baeza s n, 03010 Alicante, Spain
J Mol Cell Cardiol 37:699-704. 2004
....
Plasma angiogenin levels in acute coronary syndromes: implications for prognosisAntonio Tello-Montoliu
Cardiology Department, Hospital General Universitario, Alicante, Spain
Eur Heart J 28:3006-11. 2007
..We hypothesized abnormalities of angiogenin levels in acute coronary syndrome (ACS), with prognostic implications for predicting adverse events...
Implications of pharmacogenetics for oral anticoagulants metabolismVirginia Pérez-Andreu
Department of Hematology and Oncology, Hospital Morales Meseguer, Murcia, Spain
Curr Drug Metab 10:632-42. 2009
..There is a considerable controversy about the clinical use of genotyping before starting the anticoagulant therapy so, further randomized, prospective and large trials are required to recommend the use of pharmacogenetic testing...
Efficacy and safety of drug-eluting stent use in patients with atrial fibrillationJuan M Ruiz-Nodar
Department of Cardiology, Hospital General Universitario de Alicante, Alicante, Spain
Eur Heart J 30:932-9. 2009
..The aim of this study was to evaluate the safety and efficacy of the use of DES vs. bare-metal stents (BMS) in a cohort of patients with AF...
Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillationVicente Climent
Department of Cardiology General Hospital of Alicante, Alicante, Spain
Int J Cardiol 132:227-32. 2009
....
Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic riskAngel López-Cuenca
Department of Cardiology, Hospital Universitario Virgen Arrixaca, Murcia, Spain
Ann Med 42:562-75. 2010
..In this article, we provide an overview of the limited data about the possible influence of genetic polymorphisms on thromboembolic risk in AF, as well as the genetic influences on anticoagulant drug responsiveness...
Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillationPilar Gallego
Hematology and Medical Oncology Unit, Hospital Universitario Morales Meseguer, University of Murcia, Murcia, Spain
Eur J Clin Invest 42:1302-8. 2012
..We hypothesised that the ABI would predict mortality and adverse events in anticoagulated chronic nonvalvular AF patients...
[Plasma concentration of big endothelin-1 and its relation with plasma NT-proBNP and ventricular function in heart failure patients]Miguel Rivera
Servicio de Cardiologia, Centro de investigación Hospital La Fe, Valencia, Spain
Rev Esp Cardiol 58:278-84. 2005
..The purpose of this study was to investigate the relationship between plasma levels of big ET-1 and NT-proBNP, and between the former and ventricular function...
Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomesSilvia Montoro-García
University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham B18 7QH, UK
Atherosclerosis 227:313-22. 2013
..5 μm polystyrene beads, denoted as small-size microparticles (sMP), their relation to markers of cardiovascular repair and their impact on prognosis in patients with acute coronary syndromes (ACS)...
Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapyVanessa Roldan
Hematology and Medical Oncology Unit, Hospital Universitario Morales Meseguer, University of Murcia, Murcia, Spain
Chest 143:179-84. 2013
..We assessed the predictive value of the ATRIA bleeding score in a large cohort of patients with AF receiving anticoagulant therapy, compared with the well-validated HAS-BLED score...
Comparative determination and monitoring of biomarkers of necrosis and myocardial remodeling between radiofrequency ablation and cryoablationDiana Hernandez-Romero
Servicio de Cardiologia, Hospital Universitario Virgen de la Arrixaca, Universidad de Murcia, Murcia, Spain
Pacing Clin Electrophysiol 36:31-6. 2013
..There is scarce information on biomarkers' behavior after cryoablation. Our aim was to study biomarkers of necrosis, inflammation, and interstitial remodeling after two different approaches: RF versus cryoablation...
[Myocardial fibrosis in hypertrophic cardiomyopathy]Eduardo Payá
Servicio de Cardiologia, Hospital General Universitario, Alicante, Espana
Rev Esp Cardiol 58:585-6. 2005
Prognostic value of mean platelet volume in patients with non-ST-elevation acute coronary syndromeAngel A López-Cuenca
Cardiology Department, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
Angiology 63:241-4. 2012
..In conclusion, patients with nSTEACS present with larger platelets than healthy controls, however this parameter did not show an independent prognostic significance at 6-month follow-up...
Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathyEsteban Orenes-Piñero
Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
J Renin Angiotensin Aldosterone Syst 12:521-30. 2011
..The main objective of this review is to provide an overview of the role of different polymorphisms identified in the RAAS, in patients with HCM...
Prevalence and prognostic influence of peripheral arterial disease in patients >or=40 years old admitted into hospital following an acute coronary eventV Bertomeu
Hospital Universitario de San Juan, Alicante, Spain
Eur J Vasc Endovasc Surg 36:189-96. 2008
..We aimed to study the prevalence of PAD in patients with an acute coronary syndrome (ACS) and to evaluate its influence in hospital clinical outcomes...
Common carotid artery intima-media thickness and intracranial pulsatility index in non-ST-elevation acute coronary syndromesAntonio Tello Montoliu
Cardiology Department, Hospital General Universitario, Alicante, Spain
Cerebrovasc Dis 24:338-42. 2007
..The relation to the prognosis after an acute event was also assessed...
[Should we add antiplatelet therapy to oral anticoagulation in patients with atrial fibrillation and vascular disease? Review of available evidence]Jose Manuel Andreu
Servicio de Cardiologia, Hospital Universitario Virgen de la Arrixaca, Murcia, Espana
Arch Cardiol Mex 82:248-51. 2012
..Current recommendation is to add antiplatelet drug to oral anticoagulation in patients with atrial fibrillation (AF) and vascular disease. However, it is debatable to join both antithrombotic drugs in stable vascular disease...
Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosisFrancisco Cambronero
Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
Eur Heart J 30:139-51. 2009
..Several pathophysiological models are presented and discussed, including studies that have investigated these biomarkers for diagnostic and prognostic reasons, in relation to disease progression and/or mortality...
A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patientsRocio Gonzalez-Conejero
Hematology and Neurology Services, Hospital General Universitario, 30003 Murcia, Spain
Blood 100:2081-6. 2002
..006; odds ratio, 0.51; 95% confidence interval, 0.30-0.85)...
Growth hormone therapy and the heartVicente E Climent
Department of Cardiology, General Hospital of Alicante, Alicante, Spain
Am J Cardiol 97:1097-102. 2006
..However, these patients exhibited improved exercise capacity, especially those with childhood-onset GH deficiency...
Pharmacologic therapy in growth hormone disorders and the heartVicente Climent
Department of Cardiology, General Hospital of Alicante, Spain
Curr Med Chem 14:1399-407. 2007
..The aim of the present review is to provide an update overview describing the role of GH on acromegaly, adult GH deficiency and heart failure, as well as the influence of GH-based therapy on heart structure and function...
Hypertrophic cardiomyopathy. A study of the troponin-T gene in 127 Spanish familiesJuan R Gimeno
Servicio de Cardiologia, Hospital Virgen de la Arrixaca, El Palmar, Murcia, Espana
Rev Esp Cardiol 62:1473-7. 2009
..In conclusion, troponin-T mutations were responsible for 3% of the hypertrophic cardiomyopathy cases in our study population. The Phe87Leu mutation was associated with only mild hypertrophy but with a high risk of sudden death...
An insight of novel pharmacological therapies in hypertrophic cardiomyopathyEsteban Orenes-Piñero
Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, Ctra Madrid Cartagena, El Palmar, Murcia, Spain
Med Chem 7:275-85. 2011
..In this review, we analyse potential beneficial effects of specific experimental pharmacological agents on decreasing myocardial hypertrophy, regression of fibrosis or improving myocardial metabolic efficiency...
Pharmacogenetics in cardiovascular antithrombotic therapyFrancisco Marin
Department of Cardiology, Hospital Universitario Virgen de Arrixaca, Murcia, Spain
J Am Coll Cardiol 54:1041-57. 2009
..The present paper reviews the modulating role of different polymorphisms on individuals' responses to antithrombotic drugs commonly used in clinical practice...
Effects of pretreatment with intravenous flecainide on efficacy of external cardioversion of persistent atrial fibrillationVicente E Climent
Department of Cardiology, General Hospital of Alicante, Hospital Clinico Universitario of Valencia, Spain
Pacing Clin Electrophysiol 27:368-72. 2004
..Pretreatment with intravenous flecainide before electrical cardioversion is not useful in reducing technical failure of cardioversion, however, flecainide does not diminish the effectiveness of electrical cardioversion...
Pre and post-operative treatments for prevention of atrial fibrillation after cardiac surgeryEsteban Orenes-Piñero
Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, Ctra Madrid Cartagena, El Palmar, Murcia, Spain
Mini Rev Med Chem 12:1419-31. 2012
..The aim of this review is to analyse and determine the efficiency of existing therapies in the reduction of post-operative AF development...
[Hemolytic anemia secondary to paravalvular regurgitation]Vanessa Roldan
Unidad de Hematologia, Hospital de San Vicente, Alicante, Spain
Rev Esp Cardiol 55:987. 2002
[NT-proBNP levels and hypertension. Their importance in the diagnosis of heart failure]Miguel Rivera
Servicio de Cardiologia, Centro de investigación Hospital La Fe, Valencia, Spain
Rev Esp Cardiol 57:396-402. 2004
..N-terminal pro-brain natriuretic peptide (NT-proBNP) is useful in the diagnosis of heart failure. We compared NT-proBNP levels in patients with and without a diagnosis of arterial hypertension...
Fractional shortening-velocity ratio for assessment of aortic stenosis severity in patients with systolic dysfunctionVicente E Climent
Department of Cardiology, General Hospital of Alicante, Maestro Alonso, 109, 03010 Alicante, Spain
Int J Cardiol 92:229-34. 2003
..The objective of this study was to assess the utility of a described echocardiographic index: the fractional shortening-velocity ratio (FSVR=FS/4Vmax2) in those patients with left ventricular systolic dysfunction...
Usefulness of an abnormal ankle-brachial index for detecting multivessel coronary disease in patients with acute coronary syndromeDaniel Núñez
Servicio de Cardiologia, Hospital Universitario de San Juan, San Juan de Alicante, Alicante, Spain
Rev Esp Cardiol 63:54-9. 2010
..The aim of this study was to assess the usefulness of an abnormal ABI for identifying multivessel coronary artery disease in patients with acute coronary syndrome (ACS)...
Interactions between clopidogrel and proton pump inhibitors: a review of evidenceC Muñoz-Esparza
Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, Ctra Madrid Cartagena s n, El Palmar Murcia 30120, Spain
Curr Med Chem 18:2386-400. 2011
..In this article, we will review the current status and controversies in relation to a possible interaction between clopidogrel and PPIs...
Enzyme replacement therapy in Fabry disease: influence on cardiac manifestationsL Caballero
Department of Cardiology, Hospital Universitario Virgen de la Arrixaca of Murcia, Spain
Curr Med Chem 17:1679-89. 2010
....